We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
156 hedge funds and large institutions have $1.85B invested in Madrigal Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 60 increasing their positions, 43 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
313% more call options, than puts
Call options by funds: $101M | Put options by funds: $24.5M
40% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 43
28% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 29
5% more funds holding
Funds holding: 148 → 156 (+8)
2.89% more ownership
Funds ownership: 53.27% → 56.15% (+2.9%)
19% less capital invested
Capital invested by funds: $2.27B → $1.85B (-$424M)
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Holders
156
Holders Change
+8
Holders Change %
+5.41%
% of All Funds
3.57%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.07%
New
37
Increased
60
Reduced
43
Closed
29
Calls
$101M
Puts
$24.5M
Net Calls
+$76.7M
Net Calls Change
+$29.9M
Top Buyers
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$73.8M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$61.1M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$23.8M |
| 4 |
BlackRock
New York
|
+$21.7M |
| 5 |
State Street
Boston,
Massachusetts
|
+$21.5M |
Top Sellers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$55.8M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
-$26.6M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$25.8M |
| 4 |
PC
PointState Capital
New York
|
-$23.7M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
-$17.4M |
